EP 1529545 A3 20050601 - Integrated blood treatment module
Title (en)
Integrated blood treatment module
Title (de)
Integriertes Blutbehandlungsmodul
Title (fr)
Module intégré de traitement du sang
Publication
Application
Priority
- EP 04026340 A 20041105
- EP 03026854 A 20031124
- EP 03026855 A 20031124
- EP 03025640 A 20031107
Abstract (en)
[origin: WO2005044340A1] A fluid distribution module (1) for causing and monitoring the circulation of fluids from and to a patient through an extracorporeal blood treatment device, comprises a degassing device (11) connected to a connecting structure (10). The degassing device (11) comprises a first chamber (12) having a lower inlet (13) for a liquid and a second chamber (14) having an upper opening (79) closed by a hydrophobic membrane (78) and an outlet (15) for discharging the liquid. The connecting structure (10) has at least a first and a second conduits (20, 21) defined therein, wherein the first conduit (20) comprises a first end for connection to a discharge tube (7) from the treatment device and a second end connected to the inlet (13) of the first chamber (12) of the degassing device (11), and the second conduit (21) comprises a first end connected to the outlet (15) of the second chamber (14) of the degassing device (11) and a second end for connection to a blood return tube (6) to a patient.
IPC 1-7
IPC 8 full level
A61M 1/16 (2006.01); A61M 1/36 (2006.01); A61M 60/113 (2021.01); A61M 60/279 (2021.01); A61M 60/37 (2021.01); A61M 60/531 (2021.01); B01D 61/30 (2006.01); B01D 63/02 (2006.01)
CPC (source: EP KR US)
A61M 1/16 (2013.01 - EP KR US); A61M 1/36222 (2022.05 - EP US); A61M 1/36224 (2022.05 - EP US); A61M 1/362262 (2022.05 - EP US); A61M 1/3627 (2013.01 - EP KR US); A61M 1/3639 (2013.01 - KR); A61M 1/3641 (2014.02 - EP KR US); A61M 60/113 (2021.01 - EP KR US); A61M 60/279 (2021.01 - EP KR US); A61M 60/37 (2021.01 - EP KR US); A61M 60/531 (2021.01 - EP KR US); B01D 61/30 (2013.01 - EP KR US); B01D 63/02 (2013.01 - EP KR US); A61M 1/3639 (2013.01 - EP US); A61M 2205/12 (2013.01 - EP KR US)
Citation (search report)
- [Y] US 4231871 A 19801104 - LIPPS BENNIE J, et al
- [Y] EP 0292445 A1 19881123 - SORIN BIOMEDICA SPA [IT]
- [A] US 2003138349 A1 20030724 - ROBINSON THOMAS C [US], et al
- [A] WO 0025843 A1 20000511 - LIFESTREAM INTERNATIONAL INC [US]
- [A] EP 0591896 A2 19940413 - MINNESOTA MINING & MFG [US]
- [A] US 5441636 A 19950815 - CHEVALLET JACQUES [US], et al
- [A] US 5468388 A 19951121 - GODDARD NORMAN H [DE], et al
- [A] US 6176903 B1 20010123 - WAMSIEDLER RALF [DE]
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005044340 A1 20050519; AU 2004286782 A1 20050519; AU 2004286782 B2 20100826; AU 2004286795 A1 20050519; AU 2004286795 B2 20100826; CA 2543500 A1 20050519; CA 2543500 C 20130122; CA 2543504 A1 20050519; CA 2543504 C 20131008; EP 1529545 A2 20050511; EP 1529545 A3 20050601; EP 1529545 B1 20140409; EP 1680156 A1 20060719; EP 1680156 B1 20130508; ES 2476023 T3 20140711; HK 1097784 A1 20070706; HK 1098082 A1 20070713; KR 101099962 B1 20111228; KR 101122872 B1 20120320; KR 20060113698 A 20061102; KR 20060113704 A 20061102; US 2007269340 A1 20071122; US 2009008310 A1 20090108; US 8142383 B2 20120327; US 8206580 B2 20120626; WO 2005044341 A1 20050519
DOCDB simple family (application)
EP 2004012277 W 20041029; AU 2004286782 A 20041029; AU 2004286795 A 20041105; CA 2543500 A 20041029; CA 2543504 A 20041105; EP 04026340 A 20041105; EP 04791037 A 20041029; EP 2004012528 W 20041105; ES 04026340 T 20041105; HK 07104293 A 20070424; HK 07104310 A 20070424; KR 20067008624 A 20041105; KR 20067008799 A 20041029; US 59554604 A 20041105; US 59570504 A 20041029